Abdulrahman Al-Mashdali: Emerging Role of Anti-CD38 Therapy in ITP
Abdulrahman Al-Mashdali, Hematology Chief Fellow at Hamad Medical Corporation, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Blood Reviews:
“‘Targeting CD38 in Immune Thrombocytopenia: Rationale and a Scoping Review of Daratumumab’
In this review, we examine the emerging role of anti-CD38 therapy, particularly daratumumab, as a mechanistically distinct treatment strategy for patients with refractory or relapsed immune thrombocytopenia (ITP).
Current evidence suggests promising clinical responses, including rapid platelet recovery and durable remission in selected heavily pretreated patients.
Proud to contribute to this work alongside an outstanding team of collaborators Shehab Mohamed, Ayman Dalol.
Thank you to all my co-authors for their collaboration, expertise, and dedication throughout this project.
Published in Blood Reviews (Elsevier), a Q1 journal in Hematology with a 2025 Journal Impact Factor of 5.7.”
Title: Targeting CD38 in immune thrombocytopenia: Rationale and a scoping review of daratumumab
Authors: Abdulrahman F Al-Mashdali, Ayman Abdullah Dalol, Leen Haj Saleh, Ruba Adel Aweer, Mohammed Abdulgayoom, Honar Cherif, Shehab F Mohamed
Stay updated with Hemostasis Today.
-
Jun 6, 2026, 06:20Pedro Gaspar: The Role of CD4⁺ T Cells in APS
-
Jun 6, 2026, 06:03Mirriam Akiru: What Does Melena Indicate?
-
Jun 6, 2026, 05:59Eugene Fan: FIBOM-AI – Predicting Marrow Fibrosis From Routine Blood Counts
-
Jun 6, 2026, 05:30Rob Maloney: The Power of Partnership in Bleeding Disorders Care
-
Jun 5, 2026, 20:51Atoosa Salimi: Why Aspirin and Other Antiplatelets Are Not Effective in Preventing Lacunar Ischaemic Stroke
-
Jun 5, 2026, 18:38Annie Bauzon: Clinical Significance and Causes of RBC Anisocytosis
-
Jun 5, 2026, 18:36Nandan Lad: Microclots as the Cause of Secondary Stroke After Subarachnoid Hemorrhage
-
Jun 5, 2026, 18:32George Sands: A Thoughtful Editorial on Low-Dose Rivaroxaban in Advanced CKD
-
Jun 5, 2026, 18:29Zain Khalpey: Recognizing High-Risk Coronary Hematoma Characteristics During PCI